JUVÉDERM® VOLBELLA® with Lidocaine

Benefits and Results of Using Juvéderm Volbella with Lidocaine

• Subtle enhancement and natural-looking results
• Reduced discomfort due to lidocaine
• Long-lasting effects
• Suitable for lip enhancement and fine-line correction
• Quick recovery with minimal downtime
• Hydration retention keeps the skin plump and smooth
• Improves skin texture and refines treated areas

Juvéderm Volbella with Lidocaine Main Ingredients and Device Properties

Juvéderm Volbella with Lidocaine is a smooth, clear, colourless gel formulated with 15 mg of hyaluronic acid, 3 mg of lidocaine hydrochloride monohydrate for pain relief, and 1 ml of phosphate buffer with a pH of 7.2 to maintain stability. Its smooth gel consistency allows for easy injection, while the Vycross technology ensures longer-lasting results. The product is delivered in a sterile, single-use syringe, prioritising safety and hygiene. Additionally, its viscoelastic properties enable it to adapt to various skin types. Juvéderm Volbella is FDA-approved for both safety and efficacy.

Accessories or Items Included

Each Juvéderm Volbella with Lidocaine package contains:

• 2 pre-filled syringes (1ml each)
• 2 sterile 30G1/2” needles
• Instructions and traceability labels

Storage Conditions

Store between 2°C and 25°C, avoiding extreme temperatures and direct sunlight. Keep the product sealed in its original packaging to maintain sterility.

Mode of Administration

Juvéderm Volbella with Lidocaine is designed for injection into the superficial or mid-dermis, or directly into the lip mucosa, by a qualified healthcare professional. For treating infraorbital depressions (commonly known as the tear trough area), it is recommended to inject into the submuscular or pre-periosteal plane for precise results. A follow-up consultation is advised about two weeks after the procedure to assess any potential side effects. If necessary, a touch-up treatment with Juvéderm Volbella may be performed during this appointment to achieve optimal correction.

Post-Treatment Care

To achieve the best results and reduce the risk of complications, patients should follow these post-treatment care recommendations:

• Avoid strenuous exercise and sun exposure for 24-48 hours to minimise swelling or bruising
• Refrain from applying makeup for at least 12 hours to decrease the likelihood of infection
• Do not touch or massage the treated area to prevent displacing the filler
• Use a cold compress to ease any swelling or bruising
• Stay hydrated by drinking plenty of water to support skin healing
• Avoid alcohol for 24 hours after the treatment to lower the risk of bruising
• Sleep with your head elevated during the first night after the procedure to help minimise swelling

Potential Side Effects

Juvéderm Volbella with Lidocaine is generally well-tolerated, however, it’s important for treatment providers to inform patients about potential side effects. Common side effects may include temporary inflammation at the injection site, such as redness, swelling, bruising, tenderness, and itching as the skin heals. These effects are typically mild and resolve on their own within a few days.

Less common side effects may involve the formation of small, palpable nodules that could require correction, as well as possible discolouration or asymmetry.

Rarely, more serious side effects can occur, including infection, vascular occlusion, or scarring, which necessitate immediate medical attention. Being aware of these potential reactions can help manage patient expectations and ensure their safety throughout the treatment process.

Contraindications for the Treatment

Juvéderm Volbella with Lidocaine is not suitable for:

• Children or underage patients
• Pregnant or breastfeeding women
• Individuals allergic to hyaluronic acid, lidocaine, or bacterial proteins
• Patients with active infections or certain autoimmune conditions
• Patients suffering from untreated epilepsy
• Patients with a history of streptococcal disease
• Patients with bleeding disorders
• Individuals who have recently undergone facial surgery
• Individuals prone to developing scarring

These contraindications are essential to ensure patient safety and treatment efficacy.